4720-83-6 Usage
Description
6-Oxabicyclo[3.2.1]oct-3-en-7-one is a complex organic compound characterized by its unique bicyclic structure and enone functional group. It is a synthetic intermediate that plays a crucial role in the synthesis of various complex organic molecules, particularly in the field of pharmaceuticals and natural product synthesis.
Uses
Used in Pharmaceutical Synthesis:
6-Oxabicyclo[3.2.1]oct-3-en-7-one is used as a key intermediate in the convergent total synthesis of Leustroducsin B, a potent anti-cancer agent. Its unique structure and reactivity make it an essential component in the assembly of complex molecular frameworks, facilitating the development of new therapeutic agents.
In the Convergent Total Synthesis Industry:
6-Oxabicyclo[3.2.1]oct-3-en-7-one is used as a synthetic building block for the convergent total synthesis of complex natural products and bioactive molecules. Its incorporation into the synthesis process allows for the efficient construction of target molecules with improved yields and reduced reaction steps, ultimately leading to more efficient and cost-effective production of valuable compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 4720-83-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,7,2 and 0 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 4720-83:
(6*4)+(5*7)+(4*2)+(3*0)+(2*8)+(1*3)=86
86 % 10 = 6
So 4720-83-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H8O2/c8-7-5-2-1-3-6(4-5)9-7/h1,3,5-6H,2,4H2
4720-83-6Relevant articles and documents
Nicolaou,Lysenko
, p. 293 (1977)
Catalytic Aza-Wacker Annulation: Tuning Mechanism by the Activation Mode of Amide and Enantioselective Syntheses of Melinonine-E and Strychnoxanthine
Xie, Changmin,Luo, Jisheng,Zhang, Yuping,Huang, Sha-Hua,Zhu, Lili,Hong, Ran
supporting information, p. 2386 - 2390 (2018/04/30)
An unprecedented N-substituent of the amide was found to be crucial for the successful annulation to establish 2-azabicyclo[3.3.1]nonane and other ring skeletons in good yield. The novel catalytic aza-Wacker annulation methodology was further illustrated
METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING MUCOSITIS
-
Paragraph 00128, (2015/04/15)
Methods for treating and/or preventing mucositis comprising administering to a subject in need thereof an effective amount of at least one compound chosen from E-selectin antagonists, pharmaceutically acceptable salts of E-selectin antagonists, prodrugs of E- selectin antagonists, and pharmaceutically acceptable salts of prodrugs of E-selectin antagonists, and compositions comprising at least one of such compound.